MedPath

The effect of gabapentin in controlling the nausea and vomiting after the laparoscopic cholecystectomy surgery

Phase 2
Conditions
laparoscopic cholecystectomy.
Cholelithiasis
Registration Number
IRCT201104042080N5
Lead Sponsor
Arak university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
105
Inclusion Criteria

the age group of 20-60 years. Exclusion criteria: history of using analgesic and narcotic prior to the surgery; history of chronic lung and heart diseases; history of using corticosteroid; movement disorders; history of smoking; patient who use Gabapentin; history of allergy to gabapentin; people who need N.G tube after exiting the surgery room.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea. Timepoint: Each 2hour. Method of measurement: Chek list and physical examination and VAS score.;Vomiting. Timepoint: Each 2 hours. Method of measurement: Chek list and physical examination.
Secondary Outcome Measures
NameTimeMethod
Motion sickness. Timepoint: Each 2 hours. Method of measurement: Chek list and physical examination.;Confiusion. Timepoint: Each 2 hours. Method of measurement: Chek list and physical examination.
© Copyright 2025. All Rights Reserved by MedPath